Fasten bei Tumorerkrankungen – ist das ratsam?

Zusammenfassung

Fasten ist eine Jahrhunderte alte Praxis, die auch in vielen Religionen zu Hause ist. In die Naturheilkunde hielt das Fasten über Ärzte Einzug, die für ihre eigene Genesung positive Erfahrung damit machten. Die wissenschaftliche Forschung begann in Europa erst vor wenigen Jahren, wobei die gesundheitsförderlichen Abläufe des Fastens und ihre Bedeutung für die unterschiedlichen Erkrankungen untersucht wurden. Auch wenn für zahlreiche Erkrankungen die wissenschaftlichen Hinweise auf die gesundheitsförderliche Wirkung des Fastens zunahmen, so galt doch für Tumorerkrankungen generell, dass hier das Fasten nicht geeignet sei. Erst unlängst hat hier ein Umbruch stattgefunden. Insbesondere liegen Forschungsergebnisse für das Kurzeitfasten vor, welche zeigen, dass Fasten bei Tumorerkrankten die Belastungen durch Nebenwirkungen senkt und die Wirksamkeit der Chemotherapie verbessern kann.

Abstract

Fasting is a centuries-old practice that is common in many religions. Fasting found its way into naturopathy through doctors who made a positive experience with it for their own recovery. Only a few years ago, scientific research in Europe began to investigate the health-promoting processes of fasting and their significance for the various diseases. Even if the scientific evidence on the health-promoting effect of fasting increased for numerous diseases, it was generally not regarded suitable for patients with tumor diseases. Only recently a radical change has taken place here. In particular, there are research results for short-term fasting, which show that fasting in cancer patients reduces the burden of side effects and can improve the effectiveness of chemotherapy.

Schlüsselwörter

Fasten - Krebserkrankungen - Forschung - Leitlinien - Selbstmanagement

Key words

Fasting - cancer - research - guidelines - self-management

Publication History

Article published online:
23 March 2022

• Literatur

• 1 Lenzen-Schulte M, Zylka-Menhorn V. Autophagie: Selbstverstümmelung als Überlebensstrategie. Dtsch Arztebl International 2016; 113: 1740
• 2 Wilhelmi de Toledo F, Buchinger A, Burggrabe H. et al. Fasting therapy – an expert panel update of the 2002 consensus guidelines. Forsch Komplementmed 2013; 20: 434-443 DOI: 10.1159/000357602.
• 3 Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One 2019; 14: e0209353 DOI: 10.1371/journal.pone.0209353.
• 4 Stange R, Pflugbeil C, Michalsen A, Uehleke B. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance. Forsch Komplementmed 2013; 20: 421-426 DOI: 10.1159/000357875.
• 5 Choi IY, Piccio L, Childress P. et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Reports 2016; 15: 2136-2146 DOI: 10.1016/j.celrep.2016.05.009.
• 6 Bauersfeld SP, Kessler CS, Wischnewsky M. et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer 2018; 18: 476 DOI: 10.1186/s12885-018-4353-2.
• 7 Brandhorst S, Longo VD. Dietary restrictions and nutrition in the prevention and treatment of cardiovascular disease. Circ Res 2019; 124: 952-965 DOI: 10.1161/circresaha.118.313352.
• 8 Berger B, Jenetzky E, Köblös D. et al. Seven-day fasting as a multimodal complex intervention for adults with type 1 diabetes-feasibility, benefit and safety in a controlled pilot study. Research Square Preprint 2020; DOI: 10.21203/rs.3.rs-57497/v1.
• 9 Michalsen A. Journal Club. Forsch Komplementmed 2015; 22: 405-409 DOI: 10.1159/000443025.
• 10 Lee C, Raffaghello L, Brandhorst S. et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 2012; 4: 124ra127 DOI: 10.1126/scitranslmed.3003293.
• 11 de Groot S, Lugtenberg RT, Cohen D. et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun 2020; 11: 3083 DOI: 10.1038/s41467-020-16138-3.
• 12 Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer 2018; 18: 707-719 DOI: 10.1038/s41568-018-0061-0.
• 13 Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26: 1-22 DOI: 10.1146/annurev.nutr.26.061505.111258.
• 14 de Groot S, Vreeswijk MP, Welters MJ. et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 2015; 15: 652 DOI: 10.1186/s12885-015-1663-5.